CN103055218A - 用于治疗新生儿黄疸的中药组合物及其制备方法 - Google Patents
用于治疗新生儿黄疸的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103055218A CN103055218A CN2013100515107A CN201310051510A CN103055218A CN 103055218 A CN103055218 A CN 103055218A CN 2013100515107 A CN2013100515107 A CN 2013100515107A CN 201310051510 A CN201310051510 A CN 201310051510A CN 103055218 A CN103055218 A CN 103055218A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- herba
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 106
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 206010023138 Jaundice neonatal Diseases 0.000 title claims abstract description 19
- 201000006346 Neonatal Jaundice Diseases 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 14
- 238000011282 treatment Methods 0.000 claims abstract description 32
- 239000009636 Huang Qi Substances 0.000 claims abstract description 18
- 241000155668 Siphonostegia chinensis Species 0.000 claims abstract description 17
- 239000000706 filtrate Substances 0.000 claims description 48
- 229940079593 drug Drugs 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000008187 granular material Substances 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 229960004793 sucrose Drugs 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- 239000007779 soft material Substances 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 206010023126 Jaundice Diseases 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 33
- 230000008901 benefit Effects 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000736253 Berberis bealei Species 0.000 abstract 1
- 235000016068 Berberis vulgaris Nutrition 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000522190 Desmodium Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 235000014043 Glechoma hederacea var parviflora Nutrition 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 240000003146 Lobelia chinensis Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000179291 Mahonia aquifolium Species 0.000 abstract 1
- 244000215554 Nepeta hederacea Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000320380 Silybum Species 0.000 abstract 1
- 235000010841 Silybum marianum Nutrition 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 241000222355 Trametes versicolor Species 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 17
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 13
- 210000000232 gallbladder Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000003754 fetus Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000021130 Bilirubin encephalopathy Diseases 0.000 description 2
- 206010008014 Cephalhaematoma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000027119 bilirubin metabolic disease Diseases 0.000 description 2
- 201000001383 blood group incompatibility Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 208000036796 hyperbilirubinemia Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000001524 infective effect Effects 0.000 description 2
- 208000006663 kernicterus Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010021750 Infantile Spasms Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229960003226 nikethamide Drugs 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- WRLGYAWRGXKSKG-UHFFFAOYSA-M phenobarbital sodium Chemical compound [Na+].C=1C=CC=CC=1C1(CC)C(=O)NC([O-])=NC1=O WRLGYAWRGXKSKG-UHFFFAOYSA-M 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 90 | 52 | 27 | 11 | 87.8% |
对照组 | 90 | 43 | 31 | 16 | 82.2% |
组别 | 黄疸消退时间(d) | 日均胆红素下降值(μmol/L) | 平均住院天数(d) |
治疗组 | 7.7+1.2 | 61+12 | 7.4+1.5 |
对照组 | 12.5+2.4 | 39+6 | 12.1+1.9 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310051510.7A CN103055218B (zh) | 2013-02-17 | 2013-02-17 | 用于治疗新生儿黄疸的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310051510.7A CN103055218B (zh) | 2013-02-17 | 2013-02-17 | 用于治疗新生儿黄疸的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103055218A true CN103055218A (zh) | 2013-04-24 |
CN103055218B CN103055218B (zh) | 2014-04-23 |
Family
ID=48098312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310051510.7A Expired - Fee Related CN103055218B (zh) | 2013-02-17 | 2013-02-17 | 用于治疗新生儿黄疸的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103055218B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815174A (zh) * | 2015-04-20 | 2015-08-05 | 李英 | 一种治疗新生儿高胆红素血症的中药灌肠剂及护理方法 |
CN105287955A (zh) * | 2015-11-09 | 2016-02-03 | 张健 | 一种用于治疗黄疸的中药制剂及制备方法 |
CN105770348A (zh) * | 2016-04-30 | 2016-07-20 | 于连玲 | 一种治疗新生儿高胆红素血症的中药及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1164284C (zh) * | 2001-03-23 | 2004-09-01 | 刘渭滨 | 一种治疗新生儿黄疸的散剂 |
CN101732617A (zh) * | 2008-11-06 | 2010-06-16 | 菅晓波 | 一种治疗新生儿病理性黄疸的药膏 |
CN101757481A (zh) * | 2008-11-28 | 2010-06-30 | 吴强 | 一种治疗新生儿黄疸的中药制剂 |
CN101537159B (zh) * | 2009-04-29 | 2011-02-02 | 赵翠英 | 一种中药组合物及其制备方法和应用 |
CN101961464B (zh) * | 2010-04-27 | 2011-12-14 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗黄疸的中药组合物及其制备方法 |
-
2013
- 2013-02-17 CN CN201310051510.7A patent/CN103055218B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1164284C (zh) * | 2001-03-23 | 2004-09-01 | 刘渭滨 | 一种治疗新生儿黄疸的散剂 |
CN101732617A (zh) * | 2008-11-06 | 2010-06-16 | 菅晓波 | 一种治疗新生儿病理性黄疸的药膏 |
CN101757481A (zh) * | 2008-11-28 | 2010-06-30 | 吴强 | 一种治疗新生儿黄疸的中药制剂 |
CN101537159B (zh) * | 2009-04-29 | 2011-02-02 | 赵翠英 | 一种中药组合物及其制备方法和应用 |
CN101961464B (zh) * | 2010-04-27 | 2011-12-14 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗黄疸的中药组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
曾玉珍: "退黄汤治疗新生儿黄疸60例", 《光明中医》, vol. 27, no. 9, 30 September 2012 (2012-09-30), pages 1779 - 1780 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815174A (zh) * | 2015-04-20 | 2015-08-05 | 李英 | 一种治疗新生儿高胆红素血症的中药灌肠剂及护理方法 |
CN105287955A (zh) * | 2015-11-09 | 2016-02-03 | 张健 | 一种用于治疗黄疸的中药制剂及制备方法 |
CN105770348A (zh) * | 2016-04-30 | 2016-07-20 | 于连玲 | 一种治疗新生儿高胆红素血症的中药及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103055218B (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
CN102205108B (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
CN106267120A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
CN103156984A (zh) | 用于治疗牙龈炎的中药组合物及其制备方法 | |
CN103055218B (zh) | 用于治疗新生儿黄疸的中药组合物及其制备方法 | |
CN103550604A (zh) | 一种治疗神经性皮炎的中药 | |
CN102805834A (zh) | 一种治疗胃炎的药物及其制备方法 | |
CN103623279B (zh) | 一种治疗小儿麻疹的药物及其制备方法 | |
CN104524461A (zh) | 一种治疗心肌炎的药物组合物及其应用 | |
CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
CN104055920A (zh) | 一种治疗小儿黄疸的中药 | |
CN103007145A (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN104189608B (zh) | 一种治疗复发性口腔溃疡的中药制剂及制备方法 | |
CN107375551A (zh) | 一种治疗脾虚湿蕴型带状疱疹的中药组合物 | |
CN102716341B (zh) | 治疗急性消化性溃疡出血的中药组合物及其制备方法 | |
CN102641442B (zh) | 一种治疗复发性口疮的中药制剂 | |
CN106620408A (zh) | 一种治疗恶性葡萄胎的药物及其制备方法 | |
CN104998189A (zh) | 一种治疗风热乘脾型小儿口疮的中药散剂及其制备方法 | |
CN106266334A (zh) | 一种治疗肥胖并发高脂血症的中药组合物及针药结合应用 | |
CN105770115A (zh) | 一种治疗湿疹的中药药膏 | |
CN105381416A (zh) | 一种治疗上消化道出血的药物及其制备方法 | |
CN105497267A (zh) | 一种治疗热毒炽盛型小儿黄疸的中药组合物 | |
CN106214936A (zh) | 治疗胸腹腰部带状疱疹的中药配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Han Yinghua Inventor after: Wang Lin Inventor after: Cao Aifang Inventor after: Kong Jian Inventor before: Kong Jian |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: KONG JIAN TO: HAN YINGHUA WANG LIN CAO AIFANG KONG JIAN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD. Free format text: FORMER OWNER: KONG JIAN Effective date: 20141105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264006 YANTAI, SHANDONG PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141105 Address after: 226100, 999, Guangzhou Road, Haimen, Jiangsu, Nantong Patentee after: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD. Address before: 264006 Yantai, Yantai economic and Technological Development Zone, Zhujianglu Road,,, Career Technical College Patentee before: Kong Jian |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140423 Termination date: 20170217 |
|
CF01 | Termination of patent right due to non-payment of annual fee |